The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | O'Byrne Jason | CHIEF FINANCIAL OFFICER | Grant(A) | 650K | — | $0 |
| Jul 24, 2026 | Harmon Cyrus | Director | Sell(S) | 13K | $11.71 | $146K |
| Jul 23, 2026 | Harmon Cyrus | Director | Sell(S) | 13K | $11.58 | $145K |
| Jun 18, 2026 | Harmon Cyrus | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | Butitta Cynthia M | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | Garland J. Scott | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | Hrustanovic Gorjan | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | Clark Ian T | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | Larson Yi | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | Horning Sandra | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | Raman Prakash | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | Rappaport Andrew | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | BVF Partners L P | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2026 | Graham G. Walmsley | Director | Grant(A) | 30K | — | $0 |
| Apr 28, 2026 | Raman Prakash | Director | Grant(A) | 3K | — | $0 |
| Apr 28, 2026 | Raman Prakash | Director | Grant(A) | 24K | — | $0 |
| Mar 4, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Sell(S) | 233 | $24.69 | $6K |
| Mar 4, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Option exercise(M) | 25K | $4.37 | $109K |
| Mar 4, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Sell(S) | 25K | $24.25 | $601K |
| Mar 4, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Option exercise(M) | 25K | — | $0 |
| Mar 3, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Sell(S) | 15K | $23.01 | $345K |
| Mar 3, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Option exercise(M) | 15K | $4.37 | $66K |
| Mar 3, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Option exercise(M) | 15K | — | $0 |
| Feb 2, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Grant(A) | 56K | — | $0 |
| Feb 2, 2026 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Grant(A) | 220K | — | $0 |
| Feb 2, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Grant(A) | 250K | — | $0 |
| Feb 2, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Grant(A) | 106K | — | $0 |
| Feb 2, 2026 | Bohen Sean | PRESIDENT AND CEO, Director | Grant(A) | 850K | — | $0 |
| Feb 2, 2026 | Bohen Sean | PRESIDENT AND CEO, Director | Grant(A) | 275K | — | $0 |
| Feb 2, 2026 | Zojwalla Naseem | CHIEF MEDICAL OFFICER | Grant(A) | 106K | — | $0 |
| Feb 2, 2026 | Zojwalla Naseem | CHIEF MEDICAL OFFICER | Grant(A) | 250K | — | $0 |
| Feb 2, 2026 | Austin Sasha Lu | VP of Finance and Controller | Grant(A) | 12K | — | $0 |
| Feb 2, 2026 | Austin Sasha Lu | VP of Finance and Controller | Grant(A) | 29K | — | $0 |
| Jan 20, 2026 | Harmon Cyrus | Director | Sell(S) | 10K | $26.88 | $269K |
| Jan 15, 2026 | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Sell(S) | 100K | $28.73 | $2.9M |
| Jan 14, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Option exercise(M) | 50K | $4.87 | $244K |
| Jan 14, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell(S) | 15K | $28.60 | $429K |
| Jan 14, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell(S) | 35K | $28.99 | $1.0M |
| Jan 14, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Option exercise(M) | 50K | — | $0 |
| Jan 14, 2026 | Harmon Cyrus | Director | Sell(S) | 3K | $29.12 | $102K |
| Jan 13, 2026 | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Sell(S) | 4K | $28.01 | $107K |
| Jan 13, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Option exercise(M) | 50K | $4.87 | $244K |
| Jan 13, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell(S) | 50K | $27.60 | $1.4M |
| Jan 13, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell(S) | 200 | $28.49 | $6K |
| Jan 13, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Option exercise(M) | 50K | — | $0 |
| Jan 12, 2026 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell(S) | 10K | $28.34 | $283K |
| Dec 26, 2025 | Bohen Sean | President and CEO, Director | Gift(G) | 9K | — | $0 |
| Dec 23, 2025 | Zojwalla Naseem | Chief Medical Officer | Sell(S) | 100K | $27.66 | $2.8M |
| Dec 23, 2025 | Zojwalla Naseem | Chief Medical Officer | Option exercise(M) | 50K | $7.02 | $351K |
| Dec 23, 2025 | Zojwalla Naseem | Chief Medical Officer | Option exercise(M) | 50K | — | $0 |
| Dec 22, 2025 | Harmon Cyrus | Director | Sell(S) | 3K | $28.53 | $82K |
| Dec 22, 2025 | Zojwalla Naseem | Chief Medical Officer | Sell(S) | 100K | $28.04 | $2.8M |
| Dec 22, 2025 | Zojwalla Naseem | Chief Medical Officer | Option exercise(M) | 43K | $15.25 | $653K |
| Dec 22, 2025 | Zojwalla Naseem | Chief Medical Officer | Option exercise(M) | 7K | $7.02 | $50K |
| Dec 22, 2025 | Zojwalla Naseem | Chief Medical Officer | Option exercise(M) | 7K | — | $0 |
| Dec 22, 2025 | Zojwalla Naseem | Chief Medical Officer | Option exercise(M) | 43K | — | $0 |
| Dec 19, 2025 | Clark Ian T | Director | Option exercise(M) | 210K | $4.41 | $925K |
| Dec 19, 2025 | Clark Ian T | Director | Option exercise(M) | 22K | $3.61 | $78K |
| Dec 19, 2025 | Clark Ian T | Director | Option exercise(M) | 22K | $7.84 | $169K |
| Dec 19, 2025 | Clark Ian T | Director | Option exercise(M) | 12K | $4.08 | $49K |
| Dec 19, 2025 | Clark Ian T | Director | Sell(S) | 30K | $28.83 | $862K |
| Dec 19, 2025 | Clark Ian T | Director | Sell(S) | 193K | $29.71 | $5.7M |
| Dec 19, 2025 | Clark Ian T | Director | Sell(S) | 42K | $30.48 | $1.3M |
| Dec 19, 2025 | Clark Ian T | Director | Option exercise(M) | 210K | — | $0 |
| Dec 19, 2025 | Clark Ian T | Director | Option exercise(M) | 22K | — | $0 |
| Dec 19, 2025 | Clark Ian T | Director | Option exercise(M) | 22K | — | $0 |
| Dec 19, 2025 | Clark Ian T | Director | Option exercise(M) | 12K | — | $0 |
| Dec 19, 2025 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Gift(G) | 9K | — | $0 |
| Dec 19, 2025 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell(S) | 6K | $31.39 | $190K |
| Dec 19, 2025 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell(S) | 44K | $30.40 | $1.3M |
| Dec 19, 2025 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell(S) | 1K | $28.08 | $34K |
| Dec 19, 2025 | Zojwalla Naseem | Chief Medical Officer | Option exercise(M) | 40K | $15.25 | $610K |
| Dec 19, 2025 | Zojwalla Naseem | Chief Medical Officer | Sell(S) | 57K | $28.03 | $1.6M |
| Dec 19, 2025 | Zojwalla Naseem | Chief Medical Officer | Sell(S) | 13K | $28.93 | $374K |
| Dec 19, 2025 | Zojwalla Naseem | Chief Medical Officer | Option exercise(M) | 40K | — | $0 |
| Dec 8, 2025 | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Gift(G) | 75K | — | $0 |
| Nov 26, 2025 | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Gift(G) | 225K | — | $0 |
| Nov 25, 2025 | Rappaport Andrew | Director | Gift(G) | 36K | — | $0 |
| Nov 21, 2025 | Rappaport Andrew | Director | Option exercise(M) | 36K | $0.39 | $14K |
| Nov 21, 2025 | Rappaport Andrew | Director | Option exercise(M) | 36K | — | $0 |
| Sep 18, 2025 | Harmon Cyrus | Director | Sell(S) | 10K | $8.33 | $83K |
| Sep 18, 2025 | Harmon Cyrus | Director | Sell(S) | 3K | $8.32 | $26K |
| Sep 16, 2025 | Harmon Cyrus | Director | Sell(S) | 10K | $8.04 | $80K |
| Sep 16, 2025 | Harmon Cyrus | Director | Sell(S) | 2K | $8.08 | $15K |
| Jun 11, 2025 | BVF Inc | Director | Grant(A) | 24K | — | $0 |
| Jun 11, 2025 | Rappaport Andrew | Director | Grant(A) | 24K | — | $0 |
| Jun 11, 2025 | Butitta Cynthia M | Director | Grant(A) | 24K | — | $0 |
| Jun 11, 2025 | Harmon Cyrus | Director | Grant(A) | 24K | — | $0 |
| Jun 11, 2025 | Graham G. Walmsley | Director | Grant(A) | 24K | — | $0 |
| Jun 11, 2025 | Hrustanovic Gorjan | Director | Grant(A) | 24K | — | $0 |
| Jun 11, 2025 | Clark Ian T | Director | Grant(A) | 24K | — | $0 |
| Jun 11, 2025 | Horning Sandra | Director | Grant(A) | 24K | — | $0 |
| Jun 11, 2025 | Garland J. Scott | Director | Grant(A) | 24K | — | $0 |
| Jun 11, 2025 | Larson Yi | Director | Grant(A) | 24K | — | $0 |
| Feb 28, 2025 | Bohen Sean | PRESIDENT AND CEO, Director | Grant(A) | 650K | — | $0 |
| Feb 28, 2025 | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Grant(A) | 320K | — | $0 |
| Feb 28, 2025 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Grant(A) | 450K | — | $0 |
| Feb 28, 2025 | Zojwalla Naseem | CHIEF MEDICAL OFFICER | Grant(A) | 205K | — | $0 |
| Feb 28, 2025 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Grant(A) | 205K | — | $0 |
| Jan 10, 2025 | BVF Partners OS Ltd. | Director | Disposed to issuer(D) | 162K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-03. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for OLMA